Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
HonorHealth Research and Innovation Institute, Scottsdale, Arizona NextGen Oncology, Beverly Hills, California Cleveland Clinic, Cleveland, Ohio University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania The University of Texas MD Anderson Cancer Center, Houston, Texas